Ibrutinib ≥98%

Supplier: ADIPOGEN CORP MS
Danger

Synonyms: (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one, PCI-32765

AG-CR1-3620-M005 AG-CR1-3620-M025
102988-796EA 110.77 USD
102988-796 102988-798
Ibrutinib ≥98%
Ibrutinib

Potent and highly selective Bruton's tyrosine kinase (BTK) inhibitor. Orally bioavailable and irreversible inhibitor of BTK (IC50 = 0.5 nM) with antineoplastic activity. Binds to and irreversibly inhibits BTK activity, preventing B cell activation and B cell-mediated signaling. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. Shown to inhibit autophosphorylation of BTK (IC50 = 11nM), phosphorylation of PLCgamma (IC50 = 29nM), a substrate of BTK and phosphorylation of ERK (IC50 = 13nM).

Formula: C₂₅H₂₄N₆O₂
MW: 440.5 g/mol
Storage Temperature: Freezer
MDL Number: MFCD20261150
CAS Number: 936563-96-1

Order Now

Specification Test Results

Purity 98%
Appearance/Color White solid.
Solubility Soluble in DMSO. Slightly soluble in ethanol (1mg/ml). Insoluble in water.

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR